The cytokine scatter factor (SF) (hepatocyte growth factor) transduces various biologic actions, including cell motility, invasion, angiogenesis and apoptosis inhibition. The latter is relevant to understanding the role of SF in promoting tumor cell survival in different contexts, for example, detachment from basement membrane, growth in metastatic sites and responses to chemo-and radiotherapy. Previously, we showed that SF protects cells against apoptosis owing to DNA damage, by a mechanism involving phosphoinositol-3-kinase/c-Akt signaling. Here, we used DNA microarray assays to identify c-Aktregulated genes that might contribute to cell protection. DU-145 human prostate cancer cells were transfected7a dominant-negative mutant Akt, treated7SF and analysed for gene expression using Affymetrix arrays. These studies identified SF-regulated genes for which induction was c-Akt-dependent vs -independent. Selected microarray findings were confirmed by semiquantitative and quantitative reverse transcription-polymerase chain reaction. We tested the contribution of four SF-inducible/ c-Akt-dependent genes (AMPD3, EPHB2, MX1 and WNT4) to protection against adriamycin (a DNA topoisomerase IIa inhibitor) using RNA interference. Knockdown of each gene except EPHB2 caused a small but significant reduction in the SF cell protection. The lack of effect of EPHB2 knockdown may be due to the fact that DU-145 cells contain a single-mutant EPHB2 allele. A combination of three small interfering RNAs blocked most of the protection by SF in both DU-145 and T47D cells. These findings identify novel c-Akt-regulated genes, some of which contribute to SF-mediated cytoprotection.
Introduction
Scatter factor (SF) (hepatocyte growth factor) is a pleiotrophic cytokine that regulates cell motility, invasion, proliferation, morphogenesis, angiogenesis, tumorigenesis and transformation in different cell types and contexts. These actions are transduced through c-Met, a receptor tyrosine kinase (Bottaro et al., 1991) . SF can protect various cell types against apoptosis owing to detachment from the substratum (anoikis) (Frisch and Francis, 1994) , autoimmune responses (Futamatsu et al., 2005) , intracellular infection (Leiriao et al., 2005) , staurosporine (Bardelli et al., 1996) , the sphingolipid ceramide (Kannan et al., 2004) , hypoxia/reperfusion injury (Wang et al., 2004) and various other agents (Dworkin et al., 2004; Huh et al., 2004) . Although SF is usually cytoprotective, it can also mediate proapoptotic effects through several mechanisms (Matteucci et al., 2003) .
We reported that SF protects epithelial, carcinoma and glioma cells against apoptosis owing to DNAdamaging agents, including ionizing radiation and chemotherapy drugs, for example, adriamycin (ADR) (a DNA topoisomerase IIa inhibitor) and cis-platinum (a crosslinking agent). This protection is due to antiapoptotic signaling, inhibition of the mitochondrial apoptosis pathway and stimulation of DNA strand break repair (Fan et al., 1998 Bowers et al., 2000; Gao et al., 2001) . The protection of cancer cells against DNA damage-induced apoptosis is a clinically relevant problem because SF accumulates and c-Met is often upregulated in various tumor types, including cancers of the breast, bladder, prostate and brain (gliomas) (Jin et al., 1997; Rosen et al., 1997; Beppu et al., 2000; Knudsen and Edlund, 2004) . Thus, SF may increase tumor cell resistance to radiation and chemotherapy by blocking DNA damage-induced apoptosis and stimulating DNA repair.
We have studied the mechanisms of SF-mediated cell protection in several cell types, including MDCK canine epithelial cells, human breast and prostate cancer cells, and human and rat glioma cells. We found that SF stimulates antiapoptotic signaling from the c-Met receptor to phosphatidylinositol-3 0 -kinase (PI3K) and the cell survival-promoting serine/threonine kinase c-Akt (Bowers et al., 2000; Fan et al., 2000 Fan et al., , 2001 . The multisubstrate adapter Gab1 (Grb2-associated binder-1) and the tumor suppressor PTEN (phosphatase and tensin homolog) act as upstream inhibitors of c-Akt to block SF-mediated cell protection, whereas Pak1 (p21-associated kinase-1) acts downstream of c-Akt to mediate cell protection . SFmediated activation of nuclear factor (NF-kB) signaling requires c-Src, c-Akt and Pak1, and NF-kB signaling is required for cell protection . The purpose of this study was to identify downstream transcriptional targets of SF that are regulated through c-Akt and contribute to cell protection. These studies were carried out using DU-145 prostate cancer cells, a cell type that we utilized in previous studies of c-Met antiapoptosis signaling.
Results

Identification of SF-and c-Akt-regulated genes in DU-145 cells
The goal of this study was to identify SF-inducible genes whose expression is dependent upon c-Akt signaling. The approach was to compare the gene expression profiles of cells treated with SF in the absence or presence of a dominant-negative (DN)-Akt expression vector. Briefly, subconfluent proliferating cells were transfected with an empty vector (pcDNA3) or DNAkt and incubated7SF (100 ng/ml) for T ¼ 6 or 48 h. Four treatment conditions were tested: (1) pcDNA3 alone (control); (2) (SF þ pcDNA3); (3) DN-Akt alone and (4) (DN-Akt þ SF). DNA microarray analyses were performed using the Affymetrix HG-U133A gene chips. To identify SF-regulated genes that are dependent upon c-Akt, we compared the following: Condition 2 vs 1 (2/1): (SF þ pcDNA3)/pcDNA3 SF-inducible genes Condition 4 vs 3 (4/3): (SF þ DN-Akt)/DN-Akt SF-inducible genes with Akt inhibited Genes on both lists are SF-inducible genes whose induction does not require c-Akt, whereas those on the first list but not the second are candidate genes whose induction by SF requires c-Akt.
Gene expression alterations were considered to be significant if: (1) the log (base 2) signal ratios were X þ 0.8 (ratio ¼ 1.74) or pÀ0.8 (ratio ¼ 0.57) in at least two out of three independent experiments and (2) the corresponding P-values were significant, using the Affymetrix algorithm. The results for the 6 and 48 h time points are summarized in Table 1 . At 6 h, 49 genes exhibited SF-induced alterations in expression based on the above criteria. Among these, 19 genes (40%) were no longer altered in expression when DN-Akt was used to block c-Akt signaling. At 48 h, 104 genes showed SF-induced changes in expression and 44 of these genes (42%) were no longer changed in the presence of DN-Akt. At 48 h, we also observed a group of genes (N ¼ 114) whose expression was altered by SF only in the presence of DN-Akt. Most of these genes (90%) were decreased in expression. This group may represent genes for which c-Akt normally blocks the ability of SF to inhibit expression.
The complete lists of genes altered by SF and/or DN-Akt and the magnitudes of the alterations are provided in the Supplementary data (Supplementary Tables  S1-S9) . Genes similarly altered by SF at T ¼ 6 h in the absence vs presence of DN-Akt (SF-regulated/ c-Akt-independent genes) are listed in Supplementary  Table S1 , whereas the SF-regulated/c-Akt-dependent genes are listed in Supplementary Table S2 . The corresponding gene lists for T ¼ 48 h are shown in Supplementary Tables S3 and S4. Supplementary Table  S2 includes some genes that were induced by SF in the absence of DN-Akt, but whose expression was decreased by SF in DN-Akt-transfected cells in one or more experiments. At 48 h, 60 genes showed similar Effect of Akt on scatter factor-regulated gene expression J Xu et al SF-induced expression changes in the absence and presence of DN-Akt, whereas 54 genes showed SF-induced alterations in the absence but not presence of DN-Akt (Table 1) . In contrast to the 6 h time point, at 48 h there were a large number of genes (N ¼ 114) whose expression was altered by SF in the presence of DN-Akt but not in its absence. For most of these genes (103 of 114), expression was decreased by SF. There may be a low basal level of c-Akt signaling even in the absence of SF stimulation . Alternatively, expression of the DN-Akt protein (K179A) might have biological effects independent of inhibition of endogenous c-Akt signaling (e.g., kinaseindependent actions of Akt). Therefore, we compared gene expression in DN-Akt-vs pcDNA3-transfected cells. These comparisons revealed altered expression of N ¼ 27 and nine genes at T ¼ 6 and 48 h, respectively (Table 1) . When the same comparison was made in cells stimulated with SF (i.e., (DN-Akt þ SF) vs (pcDNA3 þ SF)), there were N ¼ 8 and 17 genes whose expression was altered at T ¼ 6 and 48 h, respectively.
Confirmation of DNA microarray findings
We used reverse transcription-polymerase chain reaction (RT-PCR) analysis (Xu et al., 2005) to confirm selected microarray results. Initially, we used semiquantitative RT-PCR analysis with quantification by densitometry to test the effect of DN-Akt on the expression of selected SF-inducible genes from Supplementary Tables S1-S4. Figure 1a shows RT-PCR analysis of seven genes upregulated by SF at T ¼ 6 h, five of which were induced only in the absence of DN-Akt (MX1, TCF8, TEB4, CYR61 and SUPAR) and two of which were induced in the absence and presence of SF (UP and PLAU). The RT-PCR assays showed reasonable agreement with the microarray data. The former five genes showed induction by SF in the absence of DN-Akt and either no induction (MX1, TCF8, TEB4 and CYR61) or very slight induction (SUPAR) in the presence of DN-Akt. Consistent with the microarray data, UP and PLAU were both induced in the absence and presence of DN-Akt. Although PHLDA2 expression was decreased by DN-Akt, the induction by SF was similar in the presence vs absence of DN-Akt. Figure 1b shows analysis of seven genes upregulated by SF at 48 h, five of which were induced only in the absence of DN-Akt (AMPD3, ECM1, WNT4, TNIP1 and LTBP2) and two of which were induced in the absence and presence of SF (STC1 and MMP1). Again, the RT-PCR results were consistent with microarray data. The former five genes were induced by SF in the absence of DN-Akt, but showed no induction (AMPD3, TNIP1 and LTBP2) or reduced induction (ECM1 and WNT4) in the presence of DN-Akt. The other two genes (STC1 and MMP1) were significantly induced by SF in the absence and presence of DN-Akt. MMP1 expression was inhibited by DN-Akt, but the induction by SF was preserved.
The ability of DN-Akt protein (K179A, a kinase dead mutant) to inhibit Akt signaling is shown in Figure 2 . Akt activation was assessed by Western blotting using an antibody that detects phosphor-Akt (serine-473). Although the pcDNA3 vector had no effect on the induction of phospho-Akt, expression of a constitutively active myristoylated mutant Akt (myr-Akt) caused phosphorylation of both Akt and the Akt target proteins mTOR (mammalian target of rapamycin) and GSK-3a/b (glycogen synthase kinase-3 a/b) (Figure 2a) . Expression of DN-Akt and myr-Akt was confirmed as an increase in total Akt levels. There were no differences in the total mTOR or GSK-3 levels, and the pcDNA3 vector did not cause Akt activation. Figure 2b shows SF-induced phosphorylation of Akt, mTOR and GSK-3 in untransfected cells, and Figure 2c shows the ability of DN-Akt to block the SF-induced phosphorylation of these proteins. Again, the DN-Akt protein was well expressed and did not alter total mTOR or GSK-3. To assess transfection efficiency, the cells were cotransfected with control plasmid pRSV-b-gal to allow counting of transfected cells after X-gal staining. For both pcDNA3-and DN-Akt-transfected cells, transfection efficiencies of about 80% were routinely obtained ( Figure 2d ).
We used quantitative (q) RT-PCR to better quantify the effects of SF and DN-Akt on selected genes. We studied eight SF-inducible genes, six of which were induced only in the absence of DN-Akt (AMPD3, ECM1, EPHB2, MMP10, MX1 and WNT4) and two of which were induced in the absence and presence of DNAkt (MMP1 and STC1). The data are shown as the ratio of messenger RNA (mRNA) for the gene of interest to b-actin (control gene), normalized to the control conditions (no SF, empty pcDNA3 vector). The results are summarized as heat maps in color-coded form in Figure 3a and b. The values shown are means of three or four independent experiments illustrated using the scales shown on the right of the figures. The complete data plotted as means7s.e.m.s (corresponding to the heat maps) are provided in the Supplementary data (Supplementary Figures S1 and S2). The effect of SF and DNAkt on each gene was tested at T ¼ 6 h (Figure 3a , top) and 48 h (Figure 3b , top). For each gene, the mRNA expression was increased by SF at each time point (Po0.01-0.001, two-tailed t-tests). The magnitudes of the increases were greater at 48 h than at 6 h. For AMPD3, ECM1, EPHB2, MX1 and WNT4, SF failed to induce gene expression or caused only a modest increase in expression (o1.6-fold) in the presence of DN-Akt. For MMP10, SF induced three-to five-fold increases in mRNA levels in the presence of DN-Akt, but these levels were significantly less than in the absence of DN-Akt (Po0.001). The ability of SF to stimulate expression of MMP1 and STC1 was similar in the presence or absence of DN-Akt.
We used qRT-PCR to analyse expression of five genes whose expression was induced by DN-Akt in the presence and/or absence of SF at T ¼ 6 and/or 48 h: BRCA1 splice variant, clone 24787 (PLXDC1), two interferon-inducible genes (IFI-6-16 and IFIT1) and MEK5C (Supplementary Tables S6-S9 Role of SF/Akt-regulated genes in protection against ADR We selected four SF-induced genes for which induction is regulated by c-Akt for further study: AMPD3, EPHB2, MX1 and WNT4, and we used RNA Effect of Akt on scatter factor-regulated gene expression J Xu et al interference to test the contribution of each gene to protection by SF against DNA damage owing to ADR. Cell viability was measured using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assays. qRT-PCR assays confirmed that small interfering (si) RNAs against each gene decreased transcript levels in the absence or presence of SF, but control siRNAs had little or no effect on mRNA levels. The qRT-PCR data are shown as heat maps in Figure 3c (see Supplementary Figure S5 for the complete data).
None of the gene-specific or control siRNAs altered the viability of cells treated without or with ADR. In the absence of siRNA, SF increased cell viability of ADRtreated cells by þ 23-27% (from 47-49 to 71-75%) in different experiments (Figure 4a-d ). There were no differences in cell viability owing to the control siRNAs. However, three of the four gene-specific siRNAs (AMPD3, MX1 and WNT4) reduced SF-mediated protection from þ 23-27 to þ 14-16% (Po0.02). Although this is only a partial effect, it is reproducible. In contrast, EPHB2-siRNA had no effect on protection by SF (Figure 4b ) (see Discussion).
In Figure 4e , we tested a combination of three gene-specific siRNAs (50 nM each of AMPD3, MX1 and WNT4) compared to 150 nM of control siRNA. The combination of siRNAs reduced SF-mediated protection from þ 24 to þ 9%, suggesting that this combination is more effective than the individual siRNAs in blocking protection by SF. However, the effect was still not complete. We also tested the same combination of siRNAs for their effect on protection against ADR in another cell line (T47D human breast cancer cells). Although the degree of protection by SF was less in T47D cells ( þ 14-15%) than in DU-145 cells ( þ 24%), the combination of genespecific siRNAs gave a substantial reduction in protection of T47D cells (from þ 14-15% down to þ 5%) (Figure 4f ). Thus, the results for T47D cells were qualitatively similar to those for DU-145. We performed Western blotting to confirm the ability of each gene-specific siRNA to knock down the protein levels in DU-145 cells. Here, each gene-specific siRNA (AMPD3, EPHB2, MX1 and WNT4) significantly reduced the corresponding protein levels, whereas the control siRNAs had little or no effect on the protein levels of the specific genes, and the gene-specific siRNAs had little or no effects on the protein levels of the control gene (a-actin) (Figure 4g ).
We performed qRT-PCR corresponding to each assay condition tested in Figure 4a -d in order to evaluate the expression levels for AMPD3, EPHB2, MX1 and WNT4 in cells treated with different combinations of SF, ADR and siRNAs. The mRNA levels were expressed relative to b-actin and normalized to the control value (no SF, no ADR no siRNA). The gene-specific siRNAs reduced the levels of gene expression whether in the presence or absence of SF or in the presence or absence of ADR (Supplementary Figures  S6a-d) . Interestingly, exposure to ADR reduced the SF-induced increases of gene expression, and the gene expression levels were further reduced by addition of gene-specific siRNAs.
Role of c-Akt, Pak1 and NF-kB in SF-mediated cell protection Previously, we showed that c-Akt, Pak1 and NF-kB signaling are required for protection against ADR by SF . c-Akt and Pak1 are also required for SF-induction of NF-kB transcriptional activity . Here, we tested the combined roles of c-Akt/Pak1 and NF-kB in the protection of DU-145 cells against ADR, by the use of wild-type Akt (wt-Akt), wt-Pak1 and mutant non-phosphorylatable IkB super-repressor (S32,36A) expression vectors . The data in Figure 5 represent the means from three independent experiments, each of which utilized six replicate wells per assay condition. SF gave a þ 40-47% increase in cell viability of ADR-treated cells (Po0.001) that was mimicked by exogenous wt-Akt (Figure 5a ) and wt-Pak1 (Figure 5b ) in the absence of SF. SF plus wt-Akt or (SF þ wt-Pak1) gave slightly higher survival rates than did either agent alone, but mutant IkB abrogated the increases in survival owing to wt-Akt or wt-Pak1 alone or in combination with SF. Thus, hyper-activation of Pak1 or Akt pathways does Effect of Akt on scatter factor-regulated gene expression J Xu et al not overcome the inhibition of protection by IkB, suggesting that NF-kB acts downstream of these mediators.
In Figure 5c , we tested the ability of SF to protect DU-145 cells against apoptosis, using an immunofluorescence assay to assess terminal deoxytransferase end labeling (TUNEL) as an indicator of apoptosis. These assays are complementary to the MTT assays, which measure the ability of intact mitochondria to convert a tetrazolium salt to formazan. The MTT assay is sensitive to both apoptotic and non-apoptotic cell death, whereas the TUNEL assay only detects cells undergoing apoptosis. The upper panel shows photomicrographs of cells treated with different combinations of DN-Akt, SF and ADR and assayed for TUNEL immunoreactivity 24 h after exposure to ADR, and the lower panel shows the quantification of the TUNEL assays. At this time point, ADR-treated cultures exhibited 30-35% apoptotic cells, and (DN-Akt þ ADR)-treated cultures exhibited a similar percentage of apoptotic cells. Cultures treated with (SF þ ADR) showed a reduction in the percentage of apoptotic cells to basal levels (2-3%). In contrast, cultures treated with (DN-Akt þ SF þ ADR) showed about 20% apoptotic cells, indicating that DN-Akt blocked the ability of SF to protect against ADR-induced apoptosis.
Discussion
We identified genes regulated by SF in DU-145 prostate cancer cells through c-Akt-dependent vs -independent pathways. c-Akt is activated by growth factor signaling through PI3K and, in turn, regulates the phosphorylation of various downstream targets, including proapoptotic proteins (e.g., BAD and caspase-9), other kinases (e.g., GSK-3, Pak1, apoptosis signal-regulating kinase 1 (ASK1) and mTOR), Forkhead family transcription factors (e.g., FKHR and AFX), NF-kB, a tumor suppressor (BRCA1), an E3 ubiquitin ligase (MDM2) and steroid hormone receptors (e.g., estrogen receptoralpha (ER-a)) (reviewed by Mitsiades et al., 2004) . Signaling pathways downstream of c-Akt contribute to cell proliferation and survival, but the gene expression alterations that mediate these functions of c-Akt are not well understood.
The finding that about 40% of the SF-inducible genes were not similarly induced in the presence of DN-Akt was not surprising. However, the finding of a large number of genes, for which SF-induced changes (mostly decreases in expression) were observed only in the presence of DN-Akt at T ¼ 48 h, was somewhat surprising. The significance of these gene expression changes is unclear. However, we raise the possibility that the inhibition of c-Akt may divert the SF signal into other directions that would not be observed in the presence of active c-Akt. The idea that SF signaling may be diverted through some pathways at the expense of others is suggested by the observations that SF mediates different biologic responses in a cell-type and context-specific manner (reviewed by Rosen et al., 1994) . Identification of critical signaling molecules that determine which specific pathway predominates will help to elucidate the mechanisms of SF action. One such nodal protein may be Gab1, which diverts the SF signal toward morphogenesis (Schaeper et al., 2000) and away from antiapoptosis signaling .
We confirmed that DN-Akt effectively blocked Akt signaling by showing that the DN-Akt protein is well expressed and that it blocks phosphorylation of Akt (a correlate of Akt activation). We further showed that DN-Akt blocked the ability of SF or an activated mutant Akt protein (myr-Akt) to stimulate signaling downstream of Akt (phosphorylation of mTOR and GSK3). Finally, we showed that DN-Akt reversed the SF-mediated protection against ADR-induced apoptosis.
We confirmed a subset of the SF-and c-Akt-mediated gene expression alterations using semiquantitative and qRT-PCR analyses. Among four confirmed SF-and c-Akt-regulated genes tested, siRNAs for three of the four genes (AMPD3, MX1 and WNT4) reduced but did not abrogate the SF-mediated protection of DU-145 cells against ADR. Although the effects of these siRNAs on cell protection were relatively small, none of them reduced survival in cells treated with ADR alone, and the reductions of survival in cells treated with SF þ ADR were reproducible. A combination of siRNAs for AMPD3, MX1 and WNT4 gave a greater effect than any individual siRNA, although the combination of siRNAs did not abrogate the SF-mediated protection. This combination of siRNAs also attenuated SF protection of T47D cells against ADR, suggesting the relevance of our findings to other cell types. None of these genes are known to be directly involved in apoptosis or cell survival pathways. However, a role for Wnt4 in germ cell survival in the ovary has been proposed (Yao et al., 2004) , and high levels of adenosine that might result from a deficiency of AMPD3 can cause toxicity and apoptosis (Barry and Lind, 2000) . MX1 is an interferon-inducible protein that mediates resistance to influenza and a member of the family of large GTPases. A role for MX1 in cell survival has not, to our knowledge, been described. Thus, our study has identified three novel SF-regulated/c-Akt-dependent genes that contribute to SF protection against DNA damage.
siRNA for a fourth SF-and c-Akt-regulated gene (EPHB2) had no effect on SF protection of DU-145 cells. EPHB2 encodes an ephrin receptor that mediates developmental processes (neurogenesis) and regulates cell adhesion and migration (Cutforth and Harrison, 2002) . EPHB2 has been identified as a potential prostate tumor suppressor that is genetically inactivated in DU-145 cells, in which one EPHB2 allele is deleted, whereas the other carries a truncating mutation (Huusko et al., 2004) . Thus, it is not surprising that EPHB2-siRNA had no effect on cell survival in DU-145 cells.
We also identified a set of genes regulated by DN-Akt (in the absence or presence of SF), including a BRCA1 splice variant, two interferon-regulated genes (IFIT1 and G1P3), a MAP kinase kinase (MEK5C) and a plexin-like domain containing protein (PLXDC1, also called tumor endothelial marker 7 (TEM7)). The induction of these genes by DN-Akt may be due to inhibition of basal Akt signaling owing to other growth factors present in serum or produced by the cells. Alternatively, these gene expression changes might be due to sequestration of signaling proteins by the DNAkt protein, which alters other signaling pathways. Finally, alterations in gene expression by DN-Akt may be due to introduction of foreign DNA into the cell, but control conditions always included an empty vector.
Considerably more is known about Akt phosphorylation targets (e.g., BAD, GSK-3, Pak1, ASK1, mTOR, Forkhead family, NF-kB and others, see above) than about the downstream Akt-regulated genes. In some cases, Akt-regulated genes may be inferred by their identification as target genes for transcription factors activated by Akt. Thus, the urokinase receptor (UPAR), a known target of NF-kB (Sliva, 2004) , was upregulated by SF in an Akt-dependent manner in our study. Published studies on Akt-regulated gene expression have mostly examined the effects of a constitutively active Akt in different cell types and tissues. In a mouse transgenic model of prostate-restricted overexpression of Akt activity, increased expression of three genes that we found to be SF-and Akt-regulated (UPAR, EPHB2 and IFIT1) was observed in the prostates of transgenic mice relative to non-transgenic animals (Majumder et al., 2003) . Expression of a constitutively active (myr) Akt led to increased expression of PHLDA1 (TDAG51) (Kuhn et al., 2001 ), a gene that was induced by SF at T ¼ 48 h; however, PHLDA1 expression was Akt-independent in our study. A transcriptosomal analysis of the effects of chronic Akt activation in the heart did not reveal any overlap with our results, nor did a study of Akt-induced gene expression in human umbilical vein endothelial cells (Cook et al., 2002; Kim et al., 2005) . Thus, cell or tissue-type specificity and the context of Akt activation (i.e., owing to a cytokine or an activated Akt protein) may contribute to Akt-regulated gene expression.
Interestingly, in this study of DU-145 cells, we found that SF caused an increase in the expression of thrombospondin 1 (THBS1) (Supplementary Table S2 ). In other cell types, SF caused a decrease in THBS1 expression (Zhang et al., 2003) . Thus, the effect of SF on THBS1 expression may be cell type-dependent or dependent upon cell type-specific signaling effects. In any case, we do note that we identified several known SF-inducible genes in our study, including uPA (urokinase), its receptor (uPAR) and MMP-1 (interstitial collagenase).
Materials and methods
Cell lines and culture
Human prostate (DU-145) and breast (T47D) cancer cells were obtained from the American Type Culture Collection (Manassas, VA, USA). The cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 5% fetal calf serum, non-essential amino acids (100 mM), L-glutamine (5 mM), streptomycin (100 mg/ml) and penicillin (100 units/ml) (purchased from BioWhittaker, Walkersville, MD, USA), and were subcultured at weekly intervals using trypsin.
Reagents
Recombinant human two-chain SF was generously provided by Dr Ralph Schwall, Genentech Inc. (South San Francisco, CA, USA). ADR and MTT dye were purchased from the Sigma Chemical Co. (St Louis, MO, USA).
Expression vectors
Vectors encoding wt-Akt, an active (myr) mutant Akt and a DN kinase inactive (K179A) mutant Akt (DN-Akt) (in the pCIS2 vector) were provided by Dr Michael Quon (National Heart, Lung and Blood Institute, Bethesda, MD, USA) (Cong et al., 1997 ). An expression vector encoding wt-Pak1 (Adam et al., 2000) was provided by Dr R Kumar (University of Texas MD Anderson Cancer Center, Houston, TX, USA). The pCMV4-IkB-a (S32,36A) vector encodes a non-phosphorylatable mutant 'super-repressor' IkB-a (Brockman et al., 1995) .
Transient transfections
Subconfluent proliferating cells were transfected overnight with the vector of interest or the empty pcDNA3 vector (Invitrogen, Carlsbad, CA, USA) (15 mg of plasmid DNA per 100-mm dish) using Lipofectamine (Life Technologies, Gaithersburg, MD, USA) and washed several times. To measure the transfection efficiency, cells were co-transfected with plasmid pRSV-b-gal (Promega Corp., Madison, WI, USA) to allow staining with X-gal and counting of transfected (blue-staining) cells.
Isolation of RNA
The total cell RNA was extracted using TRIzol Reagent (Life Technologies), according to the manufacturer's instructions. The RNA was treated with DNase and precipitated using 95% ethanol before cDNA synthesis. Isolated RNA was Figure 3 qRT-PCR analysis of gene expression shown as heat maps. (a) SF-and Akt-regulated gene expression (T ¼ 6 h). DU-145 cells were transfected with DN-Akt or pcDNA3 vector, incubated7SF (100 ng/ml) for T ¼ 6 h and harvested for qRT-PCR assays. Expression of eight SF-inducible genes (MX1, WNT4, AMPD3, MMP1, ECM1, STC1, MMP10 and EPHB2) and five DN-Aktinducible genes (BRCA1 splice variant, IFIT1, G1P3, MEK5C and PLXDC1) were quantified relative to control conditions (pcDNA3, no SF) and corrected for the control gene (b-actin). The values shown are means of 3-4 experiments shown in color-coded form. (b) SF-and Akt-regulated gene expression (T ¼ 48 h). Assays were performed as above, except that a 48 h incubation with SF was used rather than a 6 h incubation. (c) Knockdown of four SF-and c-Akt-regulated genes by RNA interference. siRNAs were prepared for four genes shown to be induced by SF in a c-Akt-dependent manner (WNT4, MX1, AMPD3 and EPHB2). DU-145 cells were pretreated with gene-specific or control siRNAs (50 nM) for 48 h, treated7SF (100 ng/ml) for 6 or 48 h and harvested for RNA isolation and qRT-PCR assays. The mRNA values were expressed relative to the control gene (b-actin), normalized to the controltreated cells ( þ pcDNA3, 0 SF) and plotted as a heat map. electrophoresed through 1.0% agarose-formaldehyde gels to verify the quality of the RNA, and RNA concentrations were determined from absorbance measurements at 260 and 280 nm.
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Affymetrix microarrays
Microarray analyses were performed at the Microarray Core Facility of the North Shore-Long Island Jewish Research Institute. After cell treatments and RNA extraction, cRNA synthesis, gene chip hybridizations and data analyses were performed as described earlier (Carter et al., 2002) . For each treatment condition and time point, three independent experiments were performed. The Affymetrix HG-U133A gene chip, which contains about 22 000 probe sets for known human genes plus expressed sequences tagged, was used for these studies. This chip includes a set of maintenance genes to facilitate the normalization and scaling of array data. The normalization genes express consistent levels of transcripts over a diverse set of tissues. The expression value for each gene was calculated using Affymetrix Microarray Suite software version 5.0. The filtering criteria are described in the text. Effect of Akt on scatter factor-regulated gene expression J Xu et al
Semiquantitative RT-PCR RT-PCR assays were performed as described before Yuan et al., 2001) . The reaction conditions were individually optimized for each gene product. Cycle numbers were adjusted so that each reaction fell into the linear range of product amplification. b-Actin and b 2 -microglobulin were used as control genes. PCR products were analysed by electrophoresis in 1% agarose gels with 0.1 mg/ml of ethidium bromide. The gels were photographed under ultraviolet light.
Quantitative RT-PCR qRT-PCR was carried out as described before (Xu et al., 2005) . As a control, the mRNA level of b-actin was determined in each PCR assay and used to correct for experimental variations. The PCR primer sequences are shown in Supplementary Table S10 .
ADR treatment
Subconfluent proliferating cells in 100-mm dishes or 96-well plates were incubated7SF (100 ng/ml for 48 h) in serum-free DMEM and then sham-treated (control) or treated with ADR (10 mM for 2 h at 371C) in complete medium (DMEM plus 5% fetal calf serum). Cultures were washed three times to remove the ADR and post-incubated in fresh, drug-free complete medium at 371C for 48 h. The cells were then harvested for Western blotting, RT-PCR or MTT assays.
MTT assays
This assay is based on the ability of viable mitochondria to convert MTT (a soluble tetrazolium salt) to formazan (Alley et al., 1988) . Cells were seeded into 96-well dishes (2000 cells per well), incubated for 24-48 h to allow attachment and entry into the cell cycle, pre-incubated7SF (100 ng/ml Â 48 h), treated with ADR (2 h), post-incubated for 48 h and tested for MTT dye conversion. Cell viability was calculated as the amount of MTT dye conversion relative to sham-treated control cells.
TUNEL assays
Cells cultured on slides were subjected to the desired treatments and fixed in 4% paraformaldehyde (pH 7.4) for 10 min, and the slides were processed using the ApopTag Fluorescein In Situ Apoptosis Detection Kit (Chemicon International Inc., Temecula, CA, USA), according to the manufacturer's instructions. This assay detects fragmented apoptotic DNA by an indirect TUNEL method, using an antidigoxigenin antibody that is conjugated to a fluorescein reporter molecule. The apoptotic cells were analysed by fluorescence microscopy. At least 300 cells were counted, and the percent of apoptotic cells was determined. Three independent experiments were performed, and the results were expressed as means7s.e.m.s.
Small interfering RNAs siRNAs for human AMPD3, EPHB2, MX1 and WNT4 were designed and synthesized by Ambion (Austin, TX, USA). The sequences of these siRNAs were as follows: AMPD3 sense GGUGUUUGCUAAAGUGCUCtt, antisense GAGCACU UUAGCAAACACCtt; MX1 sense GGUCAGUUACCAG GACUACtt, antisense GUAGUCCUGGUAACUGACCtt; WNT4 sense GGAUGCUCUGACAACAUCGtt, antisense CGAUGUUGUCAGAGCAUCCtg and EPHB2 sense GGU GUGCAACGUGUUUGAGtt, antisense: CUCAAACACG UUGCACACCtt. To knock down gene expression, cells were treated with the appropriate siRNA (50 nM Â 48 h), using siPORT Amine reagent (Ambion). In each assay, a control siRNA (50 nM Â 48 h) with no homology to human, mouse or rat genes (provided by Ambion) was also tested.
Western blotting
Whole-cell extracts were prepared using radioimmunoprecipitation assay buffer (1 Â phosphate-buffered saline, 1% NP-40, 0.5% sodium desoxycholate and 0.1% sodium dodecyl sulfate (SDS)), and Western blotting was performed as described earlier (Fan et al., 1998 . Equal aliquots of wholecell protein (50 mg per lane) were electrophoresed in 4-20% SDS-polyacrylamide gradient gels and transferred to nitrocellulose membranes (Millipore, Bedford, MA, USA). The membranes were blotted using the primary antibodies of interest: anti-phospho-Akt (serine-473) (#9271S, Cell Signaling Technology (Beverly, MA, USA), 1:500 dilution); antiphospho-mTOR (#ab1093, Novus Biologicals (Littleton, CO, USA), 1:100); anti-total mTOR (#NB100-241, Novus, 1:500); anti-phospho-GSK-3a/b (#9331, Cell Signaling Technology, 1:500); anti-total GSK-3a/b (#9338, Cell Signaling Technology, 1:100); anti-EPHB4 (#sc-7284, Santa Cruz Biotechnology (Santa Cruz, CA, USA), 1:500); anti-WNT4 (#sc-5214, Santa Cruz, 1:500) and anti-a-actin (I-19, #sc-1616, Santa Cruz, 1:1000). A rabbit polyclonal antibody against MX1 was generously provided by Dr Otto Haller (Institut fu¨r Medizinische Mikrobiologie und Hygiene, Universita¨t Freiburg, Freiburg, Germany) and was utilized at a 1:250 dilution (Engelhardt et al., 2004) . A rabbit polyclonal anti-AMPD3 antiserum was generously provided by Dr Richard L Sabina (Medical College of Wisconsin, Milwaukee, WI, USA) and was used at a 1:150 dilution (Mahnke-Zizelman and Sabina, 2000) . Because of difficulty in detecting DN-Akt protein, a combination of three primary antibodies was used for Western blotting of total Akt: anti-Akt (catalog # P8103S, New England Biolabs (Beverly, MA, USA), 1:200) plus anti-Akt (#MAB17751, R&D Systems Inc. (Minneapolis, MN, USA), 1:200) plus anti-Akt (clone 302407, R&D Systems, 1:200). The membranes were blotted with the appropriate secondary antibodies (Santa Cruz, 1:1000), and protein bands were visualized via the enhanced chemiluminescence detection system (Amersham Pharmacia Biotech, Uppsala, Sweden), with colored markers (Bio-Rad Laboratories, Hercules, CA, USA) as size standards.
Statistical analyses
Statistical comparisons were made using the two-tailed Student's t-test.
